AzTrials
AzTrials

Type 2 Diabetes Mellitus (T2DM)SC-DMT2NCT07333625

Spiritual Care for Psychological and Glycemic Outcomes in Type 2 Diabetes

A study testing Spiritual Care Program and Standard Diabetes Care in people with Type 2 Diabetes Mellitus (T2DM), run by Universitas Noor Huda Mustofa at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effects of integrating spiritual care into the management of patients with type 2 diabetes mellitus. The study examines whether a structured spiritual care program can improve psychological resilience, reduce psychological distress, and help control blood glucose levels in adults with… Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Type 2 Diabetes Mellitus (T2DM)
What is being tested?
Spiritual Care Program and Standard Diabetes Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteIndonesia
Study dates
2 Jun 2024to 5 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who can read and communicate well;
  • Clinically diagnosed with type II di-abetes; and
  • Patients over the age of 40
  • Willing to participate and provide written informed consent

Who cannot join

  • Diagnosed with severe psychiatric disorders
  • Having cognitive impairment that interferes with participation

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • RSU Anna Medika Madura

    Bangkalan, East Java, 69116

Other trials in Indonesia

About this study

Official title: Integrating Spiritual Care Into Type 2 Diabetes Management: Effects on Psychological Resilience, Distress, and Glycemic Control

This study aims to evaluate the effects of integrating spiritual care into the management of patients with type 2 diabetes mellitus. The study examines whether a structured spiritual care program can improve psychological resilience, reduce psychological distress, and help control blood glucose levels in adults with type 2 diabetes. Participants receive standard diabetes care, with one group also receiving spiritual care interventions delivered by trained health professionals. The findings of this study are expected to support a more holistic approach to diabetes management that addresses both physical and psychological well-being.

Read the detailed description

This study is a randomized controlled clinical trial designed to evaluate the impact of integrating spiritual care into standard management for adults with type 2 diabetes mellitus. Psychological distress and reduced resilience are common among patients with chronic illnesses such as diabetes and may negatively influence glycemic control. Integrating spiritual care into routine diabetes management may help address these psychosocial challenges and improve overall patient well-being.

Eligible participants with type 2 diabetes mellitus were randomly assigned to one of two groups. The experimental group received standard diabetes care combined with a structured spiritual care program, while the control group received standard diabetes care alone. The spiritual care intervention was delivered by trained health professionals and included supportive spiritual counseling, reflective practices, and discussions tailored to patients' beliefs and coping needs.

Primary outcomes of the study included changes in psychological resilience, psychological distress, and glycemic control as measured by blood glucose levels. Secondary outcomes included additional psychological and clinical indicators relevant to diabetes management. Outcome assessments were conducted at baseline and after completion of the intervention period.

The study was conducted in a hospital setting in Indonesia and followed ethical principles for research involving human participants, with approval obtained from an institutional ethics committee. The findings are expected to provide evidence to support holistic and patient-centered approaches to diabetes care that integrate spiritual and psychological dimensions alongside standard medical treatment.

Being tested
Spiritual Care Program, Standard Diabetes Care
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spiritual Care ProgramBehavioural

    A structured spiritual care program integrated into standard diabetes management, including guided spiritual reflection, supportive counseling, and meaning-centered support delivered by trained healthcare providers.

  • Standard Diabetes CareBehavioural

    Standard diabetes management provided according to hospital clinical guidelines, including medical treatment, dietary counseling, and routine diabetes education.

Study groups in NCT07333625
Study groupRoleWhat they receive
Spiritual Care Plus Standard CareExperimentalParticipants received standard diabetes care combined with a structured spiritual care program.
Receives: Behavioral: Spiritual Care Program; Behavioral: Standard Diabetes Care
Standard Diabetes CareActive comparatorParticipants received standard diabetes care without additional spiritual care intervention.
Receives: Behavioral: Standard Diabetes Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological Resilience

    Psychological resilience measured using a validated resilience questionnaire, with higher scores indicating greater resilience.

    Measured: Baseline and post-intervention (4 weeks)

  2. Psychological Distress

    Psychological distress assessed using a standardized psychological distress scale, with higher scores indicating greater distress.

    Measured: Baseline and post-intervention (4 weeks)

  3. Blood Glucose Level

    Fasting blood glucose level measured in milligrams per deciliter (mg/dL).

    Measured: Baseline and post-intervention (4 Weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study start2 Jun 2024
  3. Primary completion5 Jun 2024
  4. Study completion5 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07333625
Sponsor's protocol ID
SC-DMT2-2024-AMM
Other IDs
1853/KEPK/STIKES-NHM/EC/V/2023
Acronym
SC-DMT2
Status last verified
Dec 2025
First submitted
31 Dec 2025
Last updated
12 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Koenig HG. Religion, spirituality, and health: the research and clinical implications. ISRN Psychiatry. 2012 Dec 16;2012:278730. doi: 10.5402/2012/278730. Print 2012.

    PubMed 23762764

Questions about this trial

What is this clinical trial studying?

A study testing Spiritual Care Program and Standard Diabetes Care in people with Type 2 Diabetes Mellitus (T2DM), run by Universitas Noor Huda Mustofa at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological Resilience (time frame: Baseline and post-intervention (4 weeks)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07333625, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in